Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomaterials legislation

This article was originally published in The Gray Sheet

Executive Summary

"Biomaterials Access Assurance Act" becomes law Aug. 13 following President Clinton's signing of the bill (HR 872). Both the House and Senate passed the bill, which provides liability protections for suppliers of raw materials used in implantable medical devices, the week of July 27 ("The Gray Sheet" Aug. 3, p. 7)

You may also be interested in...



GHTF Study Group One To Consider Issue Of Biomaterials Testing

Harmonizing biomaterials testing worldwide could be achieved through a global master file database, FDA Office of Device Evaluation Deputy Director Kimber Richter, MD, suggested to Study Group One July 1 at a session of the Global Harmonization Task Force's annual meeting in Bethesda, Maryland.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

UsernamePublicRestriction

Register

MT010494

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel